StrokeNCT07395180
Differentiation of Human Body Balance Disorders
A study testing Patients after stroke, Patients with posterior columns of the spinal cord and Patients with labyrinth diseases in people with Stroke and Visual Defects, run by Military Institute od Medicine National Research Institute at 1 site in Poland.
Trial summary
Our research aims to analyze the possibilities of functional assessment of imbalances in the human body. Using the available, commonly known and used tests and devices for objective examination of static and dynamic body balance, as well as changes in the tension of selected muscles of the cervical spine in static and… Read more about this study
- Who is it for?
- Ages 20 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Stroke, Visual Defects, Labyrinth Diseases
- What is being tested?
- Patients after stroke, Patients with posterior columns of the spinal cord and Patients with labyrinth diseases
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 330 participants
- Where
- 1 sitePoland
- Study dates
- 19 Jan 2026to 30 Mar 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 1) stroke patients (7 to 9 weeks after cerebellar stroke), with degenerative changes of the spine, including the cervical section, with labyrinth disorders, with visual defects, with changes in the posterior cords of the spinal cord;
- 2) functional status of patients that allows them to stand and walk in place and over a distance (Rankin ≤ 3);
- 3) Modified Ashworth Muscle Tone Scale (MAS ≤1/1+);
- 4) positive Tandem test;
- 5) no major deficits in communication, memory or comprehension which may impede correct measurement;
- 6) over 20 years of age; maximum 80 years.
Show all 10Show fewer
- The main criteria for inclusion in the control group:
- 1) healthy people with a stable trunk (100 TCT points);
- 2) having normal muscle tone (MAS=0), walking independently;
- 3) at least 20 years old; maximum 80 years.
Who cannot join
- 1) coexisting diseases considered in the study;
- 2) stroke up to seven weeks after the episode;
- 3) epilepsy;
- 4) lack of trunk stability;
- 5) lack of independent standing and walking;
- 6) high or very low blood pressure, dizziness, malaise.
Show all 13Show fewer
- Criteria for exclusion from the control group:
- 1) history of neurological or musculoskeletal disorders, such as stroke or brain injury, or other neurological conditions that may affect their ability to move the trunk and legs actively;
- 2) degenerative changes, labyrinth disorders, vision defects;
- 3) pain, dizziness;
- 4) constant use of orthopedic supplies;
- 5) severe deficits in communication, memory, or comprehension, which may make it difficult to perform the measurement correctly;
- 6) high or very low blood pressure, feeling unwell.
Trial locations and contacts
1 site in 1 country.
Poland1 site
Military Institute od Medicine National Research Institute
Warsaw, 04-141
About this study
Official title: Differentiation of Human Body Balance Disorders - Analysis of the Potential of Functional Tests in Determining the Cause of Disorders
Our research aims to analyze the possibilities of functional assessment of imbalances in the human body. Using the available, commonly known and used tests and devices for objective examination of static and dynamic body balance, as well as changes in the tension of selected muscles of the cervical spine in static and dynamic conditions, depending on visual control or its absence, we hope to identify important research tools that help to differentiate the causes of imbalances. Studies conducted on a group of healthy people and groups of patients: after a stroke, with changes in the posterior cords of the spinal cord, with labyrinth disorders, with degenerative changes in the spine, with visual impairments, and in healthy people, seem to be important in the analysis of the discussed topic. The investigators will answer the following detailed research questions: 1. Does the type of disease/disease or its absence affect the human balance in the Romberg test? 2. Do visual defects affect the tension of the muscles of the cervical spine? 3. Do changes in the muscle tension of the cervical spine affect the ability to maintain balance in the Unterberger test? 4. Do the mobility deficits in the cervical spine coincide with cervical or labyrinthine balance disorders in the differential test for vertigo and in the Fukuda test? 5. How does the tension of the muscles of the cervical spine change in the tested groups on the stable and unstable, depending on the vision control? 6. Does the type of disease/illness or its absence affect changes in the tension of the muscles of the cervical spine, and does it correlate with the balance of the body on a stable and unstable surface? The results of the research may facilitate the functional differentiation of imbalances in the human body. The investigators hypothesize that functional tests will help determine the cause of imbalance in the human body. This will allow us to determine with high probability the dominant cause of balance disorders (eye disorders, changes in the cervical spine / musculoskeletal system, labyrinth, proprioceptors, cerebellum, posterior cords of the spinal cord), already at the initial stage of diagnosis. The research will improve the process of implementing effective treatment and therapeutic procedures.
- Conditions
- Stroke, Visual Defects, Labyrinth Diseases, Cervical Spine Degenerative Disease, Healthy, Posterior Columns of the Spinal Cord
- Being tested
- Patients after stroke, Patients with posterior columns of the spinal cord, Patients with labyrinth diseases, Patients with visual defects, Patients with cervical spine degenerative disease
- Keywords
- stroke, posterior columns of the spinal cord, cervical spine degenerative disease, labyrinth diseases, visual defects, healthy, balance
- Medical subject headings
- Stroke, Vision Disorders, Labyrinth Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Patients after strokeDiagnostic test
Body posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG.
Patients with posterior columns of the spinal cordDiagnostic test
Body posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG.
Patients with labyrinth diseasesDiagnostic test
Body posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG.
Patients with visual defectsDiagnostic test
Body posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG.
Patients with cervical spine degenerative diseaseDiagnostic test
Body posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG.
Healthy participantsDiagnostic test
Body posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG.
| Study group | Role | What they receive |
|---|---|---|
| Patients after stroke | Experimental | Not described Receives: Diagnostic Test: Patients after stroke; Diagnostic Test: Patients with posterior columns of the spinal cord; Diagnostic Test: Patients with labyrinth diseases; Diagnostic Test: Patients with visual defects; Diagnostic Test: Patients with cervical spine degenerative disease; Diagnostic Test: Healthy participants |
| Patients with posterior columns of the spinal cord | Experimental | Not described Receives: Diagnostic Test: Patients after stroke; Diagnostic Test: Patients with posterior columns of the spinal cord; Diagnostic Test: Patients with labyrinth diseases; Diagnostic Test: Patients with visual defects; Diagnostic Test: Patients with cervical spine degenerative disease; Diagnostic Test: Healthy participants |
| Patients with labyrinth diseases | Experimental | Not described Receives: Diagnostic Test: Patients after stroke; Diagnostic Test: Patients with posterior columns of the spinal cord; Diagnostic Test: Patients with labyrinth diseases; Diagnostic Test: Patients with visual defects; Diagnostic Test: Patients with cervical spine degenerative disease; Diagnostic Test: Healthy participants |
| Patients with visual defects | Experimental | Not described Receives: Diagnostic Test: Patients after stroke; Diagnostic Test: Patients with posterior columns of the spinal cord; Diagnostic Test: Patients with labyrinth diseases; Diagnostic Test: Patients with visual defects; Diagnostic Test: Patients with cervical spine degenerative disease; Diagnostic Test: Healthy participants |
| Patients with cervical spine degenerative disease | Experimental | Not described Receives: Diagnostic Test: Patients after stroke; Diagnostic Test: Patients with posterior columns of the spinal cord; Diagnostic Test: Patients with labyrinth diseases; Diagnostic Test: Patients with visual defects; Diagnostic Test: Patients with cervical spine degenerative disease; Diagnostic Test: Healthy participants |
| Healthy participants | Other | Not described Receives: Diagnostic Test: Patients after stroke; Diagnostic Test: Patients with posterior columns of the spinal cord; Diagnostic Test: Patients with labyrinth diseases; Diagnostic Test: Patients with visual defects; Diagnostic Test: Patients with cervical spine degenerative disease; Diagnostic Test: Healthy participants |
What is being measured
The primary outcome is the main question the study is designed to answer.
Advanced Packaging and Heterogeneous Integration for Electronic Components and Systems (APECS)
Evaluation of body posture in the frontal and sagittal planes - Advanced Packaging and Heterogeneous Integration for Electronic Components and Systems (APECS)
Measured: Day 1
The Tandem Test
Measured: Day 1
Modified Ashworth Scale (MAS)
Measured: Day 1
Trunk Stability Test
Measured: Day 1
Rankin Scale
Measured: Day 1
NATIONAL INSTITUTES OF HEALTH STROKE SCALE (NIHSS)
Measured: Day 1
Secondary outcomes (6)
Romberg test
Measured: Day 1
Fukuda test
Measured: Day 1
Differential test for vertigo
Measured: Day 1
Body balance test on the Biodex SD platform
Measured: Day 1
Cervical spine muscle tone test using Luna EMG
Measured: Day 1
Unterberger test
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Feb 2026
- Study start19 Jan 2026
- Primary completion28 Feb 2026 (estimated)
- Study completion30 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- . Type of research - study with a control group; Study Group - patients after a stroke/cerebellum, with changes in the posterior cords of the spinal cord, with degenerative changes of the spine, including the cervical section, with labyrinth disorders, with uncorrected vision defects. Control group - healthy volunteers. Age of the respondents - range from 20 to 80 years; women and men, in the acute and subacute period of the disease, as well as healthy volunteers. The group size with a moderate effect (f = 0.25), alpha = 0.05, and test power = 0.95 will be \> 324 people (54 people in each group).
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 330 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Military Institute od Medicine National Research Institute
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Anna Olczak, Military Institute od Medicine National Research Institute
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07395180
- Sponsor's protocol ID
- 12/KRN/24
- Status last verified
- Jan 2026
- First submitted
- 18 Jan 2026
- Last updated
- 9 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Differentiation of Human Body Balance Disorders - Analysis of the Potential of Functional Tests in Determining the Cause of Disorders
- ClinicalTrials.gov ID
- NCT07395180
- Acronym / sponsor ID
- 12/KRN/24
- Conditions
- Stroke, Visual Defects, Labyrinth Diseases, Cervical Spine Degenerative Disease, Healthy, Posterior Columns of the Spinal Cord
- Keywords
- stroke, posterior columns of the spinal cord, cervical spine degenerative disease, labyrinth diseases, visual defects, healthy, balance
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 330 participants (estimated)
- Lead sponsor
- Military Institute od Medicine National Research InstituteUniversity, hospital or other
- Study start
- 19 Jan 2026 (actual)
- Primary completion
- 28 Feb 2026 (estimated)
- Study completion
- 30 Mar 2027 (estimated)
- First posted
- 9 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Our research aims to analyze the possibilities of functional assessment of imbalances in the human body. Using the available, commonly known and used tests and devices for objective examination of static and dynamic body balance, as well as changes in the tension of selected muscles of the cervical spine in static and dynamic conditions, depending on visual control or its absence, we hope to identify important research tools that help to differentiate the causes of imbalances. Studies conducted on a group of healthy people and groups of patients: after a stroke, with changes in the posterior cords of the spinal cord, with labyrinth disorders, with degenerative changes in the spine, with visual impairments, and in healthy people, seem to be important in the analysis of the discussed topic. The investigators will answer the following detailed research questions: 1. Does the type of disease/disease or its absence affect the human balance in the Romberg test? 2. Do visual defects affect the tension of the muscles of the cervical spine? 3. Do changes in the muscle tension of the cervical spine affect the ability to maintain balance in the Unterberger test? 4. Do the mobility deficits in the cervical spine coincide with cervical or labyrinthine balance disorders in the differential test for vertigo and in the Fukuda test? 5. How does the tension of the muscles of the cervical spine change in the tested groups on the stable and unstable, depending on the vision control? 6. Does the type of disease/illness or its absence affect changes in the tension of the muscles of the cervical spine, and does it correlate with the balance of the body on a stable and unstable surface? The results of the research may facilitate the functional differentiation of imbalances in the human body. The investigators hypothesize that functional tests will help determine the cause of imbalance in the human body. This will allow us to determine with high probability the dominant cause of balance disorders (eye disorders, changes in the cervical spine / musculoskeletal system, labyrinth, proprioceptors, cerebellum, posterior cords of the spinal cord), already at the initial stage of diagnosis. The research will improve the process of implementing effective treatment and therapeutic procedures.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 6
- Model description
- . Type of research - study with a control group; Study Group - patients after a stroke/cerebellum, with changes in the posterior cords of the spinal cord, with degenerative changes of the spine, including the cervical section, with labyrinth disorders, with uncorrected vision defects. Control group - healthy volunteers. Age of the respondents - range from 20 to 80 years; women and men, in the acute and subacute period of the disease, as well as healthy volunteers. The group size with a moderate effect (f = 0.25), alpha = 0.05, and test power = 0.95 will be > 324 people (54 people in each group).
| Arm | Type | Receives |
|---|---|---|
| Patients after stroke | Experimental | Diagnostic Test: Patients after stroke, Diagnostic Test: Patients with posterior columns of the spinal cord, Diagnostic Test: Patients with labyrinth diseases, Diagnostic Test: Patients with visual defects, Diagnostic Test: Patients with cervical spine degenerative disease, Diagnostic Test: Healthy participants |
| Patients with posterior columns of the spinal cord | Experimental | Diagnostic Test: Patients after stroke, Diagnostic Test: Patients with posterior columns of the spinal cord, Diagnostic Test: Patients with labyrinth diseases, Diagnostic Test: Patients with visual defects, Diagnostic Test: Patients with cervical spine degenerative disease, Diagnostic Test: Healthy participants |
| Patients with labyrinth diseases | Experimental | Diagnostic Test: Patients after stroke, Diagnostic Test: Patients with posterior columns of the spinal cord, Diagnostic Test: Patients with labyrinth diseases, Diagnostic Test: Patients with visual defects, Diagnostic Test: Patients with cervical spine degenerative disease, Diagnostic Test: Healthy participants |
| Patients with visual defects | Experimental | Diagnostic Test: Patients after stroke, Diagnostic Test: Patients with posterior columns of the spinal cord, Diagnostic Test: Patients with labyrinth diseases, Diagnostic Test: Patients with visual defects, Diagnostic Test: Patients with cervical spine degenerative disease, Diagnostic Test: Healthy participants |
| Patients with cervical spine degenerative disease | Experimental | Diagnostic Test: Patients after stroke, Diagnostic Test: Patients with posterior columns of the spinal cord, Diagnostic Test: Patients with labyrinth diseases, Diagnostic Test: Patients with visual defects, Diagnostic Test: Patients with cervical spine degenerative disease, Diagnostic Test: Healthy participants |
| Healthy participants | Other | Diagnostic Test: Patients after stroke, Diagnostic Test: Patients with posterior columns of the spinal cord, Diagnostic Test: Patients with labyrinth diseases, Diagnostic Test: Patients with visual defects, Diagnostic Test: Patients with cervical spine degenerative disease, Diagnostic Test: Healthy participants |
Who may qualify
- Ages
- 20 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (10 listed)
- 1) stroke patients (7 to 9 weeks after cerebellar stroke), with degenerative changes of the spine, including the cervical section, with labyrinth disorders, with visual defects, with changes in the posterior cords of the spinal cord;
- 2) functional status of patients that allows them to stand and walk in place and over a distance (Rankin ≤ 3);
- 3) Modified Ashworth Muscle Tone Scale (MAS ≤1/1+);
- 4) positive Tandem test;
- 5) no major deficits in communication, memory or comprehension which may impede correct measurement;
Key exclusion criteria (13 listed)
- 1) coexisting diseases considered in the study;
- 2) stroke up to seven weeks after the episode;
- 3) epilepsy;
- 4) lack of trunk stability;
- 5) lack of independent standing and walking;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Patients after strokeBody posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG. | Diagnostic test | Healthy participants, Patients after stroke, Patients with cervical spine degenerative disease, Patients with labyrinth diseases, Patients with posterior columns of the spinal cord, Patients with visual defects |
| Patients with posterior columns of the spinal cordBody posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG. | Diagnostic test | Healthy participants, Patients after stroke, Patients with cervical spine degenerative disease, Patients with labyrinth diseases, Patients with posterior columns of the spinal cord, Patients with visual defects |
| Patients with labyrinth diseasesBody posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG. | Diagnostic test | Healthy participants, Patients after stroke, Patients with cervical spine degenerative disease, Patients with labyrinth diseases, Patients with posterior columns of the spinal cord, Patients with visual defects |
| Patients with visual defectsBody posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG. | Diagnostic test | Healthy participants, Patients after stroke, Patients with cervical spine degenerative disease, Patients with labyrinth diseases, Patients with posterior columns of the spinal cord, Patients with visual defects |
| Patients with cervical spine degenerative diseaseBody posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG. | Diagnostic test | Healthy participants, Patients after stroke, Patients with cervical spine degenerative disease, Patients with labyrinth diseases, Patients with posterior columns of the spinal cord, Patients with visual defects |
| Healthy participantsBody posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG. | Diagnostic test | Healthy participants, Patients after stroke, Patients with cervical spine degenerative disease, Patients with labyrinth diseases, Patients with posterior columns of the spinal cord, Patients with visual defects |
Primary outcome
Advanced Packaging and Heterogeneous Integration for Electronic Components and Systems (APECS)
Time frame: Day 1
Evaluation of body posture in the frontal and sagittal planes - Advanced Packaging and Heterogeneous Integration for Electronic Components and Systems (APECS)
The Tandem Test
Time frame: Day 1
Modified Ashworth Scale (MAS)
Time frame: Day 1
Trunk Stability Test
Time frame: Day 1
Rankin Scale
Time frame: Day 1
NATIONAL INSTITUTES OF HEALTH STROKE SCALE (NIHSS)
Time frame: Day 1
6 secondary outcomes
Romberg test
Time frame: Day 1
Fukuda test
Time frame: Day 1
Differential test for vertigo
Time frame: Day 1
Body balance test on the Biodex SD platform
Time frame: Day 1
Cervical spine muscle tone test using Luna EMG
Time frame: Day 1
Unterberger test
Time frame: Day 1
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Stroke
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
RecruitingObservational study
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
Acute Ichemic Stroke
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Aneurysm Hemorrhage
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Patients after stroke, Patients with posterior columns of the spinal cord and Patients with labyrinth diseases in people with Stroke and Visual Defects, run by Military Institute od Medicine National Research Institute at 1 site in Poland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 9 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Advanced Packaging and Heterogeneous Integration for Electronic Components and Systems (APECS) (time frame: Day 1). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2026.